• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肾移植受者中的恶性胸膜间皮瘤。

Malignant pleural mesothelioma in a kidney transplant recipient.

机构信息

Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Thorac Cancer. 2021 Apr;12(8):1260-1263. doi: 10.1111/1759-7714.13917. Epub 2021 Mar 4.

DOI:10.1111/1759-7714.13917
PMID:33660933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8046129/
Abstract

Post-transplantation malignancy is one of the most common complication-related mortality in transplant recipients. Here, we report the case of a kidney transplant patient for 2 years with malignant pleural effusion that was subsequently diagnosed as malignant pleural mesothelioma.

摘要

移植后恶性肿瘤是移植受者最常见的并发症相关死亡原因之一。在这里，我们报告了一例肾移植术后 2 年的患者，其患有恶性胸腔积液，随后被诊断为恶性胸膜间皮瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccd/8046129/1d46ee66f8bb/TCA-12-1260-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccd/8046129/c433e5895019/TCA-12-1260-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccd/8046129/1d46ee66f8bb/TCA-12-1260-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccd/8046129/c433e5895019/TCA-12-1260-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccd/8046129/1d46ee66f8bb/TCA-12-1260-g003.jpg

相似文献

1
Malignant pleural mesothelioma in a kidney transplant recipient.肾移植受者中的恶性胸膜间皮瘤。
Thorac Cancer. 2021 Apr;12(8):1260-1263. doi: 10.1111/1759-7714.13917. Epub 2021 Mar 4.
2
Pleural mesothelioma classification update.胸膜间皮瘤分类更新。
Virchows Arch. 2021 Jan;478(1):59-72. doi: 10.1007/s00428-021-03031-7. Epub 2021 Jan 21.
3
Perspectives on the Treatment of Malignant Pleural Mesothelioma.恶性胸膜间皮瘤的治疗前景
N Engl J Med. 2021 Sep 23;385(13):1207-1218. doi: 10.1056/NEJMra1912719.
4
Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma.恶性胸膜间皮瘤患者胸膜活检诊断难题病例的临床特征。
Gen Thorac Cardiovasc Surg. 2020 Aug;68(8):820-827. doi: 10.1007/s11748-020-01295-5. Epub 2020 Jan 24.
5
Imaging in pleural Mesothelioma: A review of the 16th International Conference of the International Mesothelioma Interest Group.胸膜间皮瘤的影像学：第 16 届国际间皮瘤兴趣小组国际会议综述。
Lung Cancer. 2024 Jul;193:107832. doi: 10.1016/j.lungcan.2024.107832. Epub 2024 May 31.
6
Low-Dosage Apatinib as Rescuing Treatment in Advanced Malignant Pleural Mesothelioma.低剂量阿帕替尼作为晚期恶性胸膜间皮瘤的挽救治疗
Am J Ther. 2020 May/Jun;27(3):e326-e327. doi: 10.1097/MJT.0000000000000992.
7
Medical Thoracoscopy, Computed Tomography-guided Biopsy, and Ultrasound-guided Biopsy for Malignant Pleural Mesothelioma: A Systematic Review.医学胸腔镜检查、计算机断层扫描引导下活检及超声引导下活检用于恶性胸膜间皮瘤：一项系统评价
Anticancer Res. 2021 May;41(5):2217-2225. doi: 10.21873/anticanres.14998.
8
[Diffuse Intraparenchymal Mesothelioma: An Atypical Presentation].[弥漫性脑实质内间皮瘤：一种非典型表现]
Acta Med Port. 2020 Feb 3;33(2):143-146. doi: 10.20344/amp.11406.
9
Malignant pleural neoplasm with both differentiation of epithelioid mesothelioma and squamous-cell carcinoma, a rare phenomena.具有上皮样间皮瘤和鳞状细胞癌分化的恶性胸膜肿瘤，一种罕见的现象。
Diagn Cytopathol. 2021 Jun;49(6):E234-E237. doi: 10.1002/dc.24686. Epub 2020 Dec 21.
10
Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma With Routine Positron Emission Tomography Imaging.诊断性腹腔镜检查结合常规正电子发射断层成像术可改善恶性胸膜间皮瘤的分期。
Ann Thorac Surg. 2021 Nov;112(5):1568-1574. doi: 10.1016/j.athoracsur.2020.08.113. Epub 2020 Dec 2.

本文引用的文献

1
SV40 and human mesothelioma.猴空泡病毒40与人类间皮瘤
Transl Lung Cancer Res. 2020 Feb;9(Suppl 1):S47-S59. doi: 10.21037/tlcr.2020.02.03.
2
Posttransplant lymphoproliferative disorders in kidney transplant recipients: a retrospective cohort analysis over two decades in Hong Kong.肾移植受者的移植后淋巴细胞增生性疾病：香港二十年回顾性队列分析
Oncotarget. 2017 Jun 30;8(57):96903-96912. doi: 10.18632/oncotarget.18890. eCollection 2017 Nov 14.
3
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.
IASLC 间皮瘤分期项目：对即将发布的第八版胸膜间皮瘤 TNM 分类中 T 描述符的修订建议。
J Thorac Oncol. 2016 Dec;11(12):2089-2099. doi: 10.1016/j.jtho.2016.08.147. Epub 2016 Sep 26.
4
First reported finding of a Malignant Pleural Mesothelioma in a patient post Liver Transplant.
Ir Med J. 2016 Apr 11;109(4):398.
5
Malignancy-related mortality following kidney transplantation is common.肾移植后与恶性肿瘤相关的死亡率较高。
Kidney Int. 2014 Jun;85(6):1395-403. doi: 10.1038/ki.2013.458. Epub 2013 Nov 20.
6
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009.意大利 1997-2009 年 7217 例肾移植受者队列的新发癌症风险。
Eur J Cancer. 2013 Jan;49(2):336-44. doi: 10.1016/j.ejca.2012.09.013. Epub 2012 Oct 10.
7
Incidence of malignancy after living kidney transplantation: a multicenter study from iran.活体肾移植后恶性肿瘤的发生率：一项来自伊朗的多中心研究。
J Cancer. 2012;3:246-56. doi: 10.7150/jca.3042. Epub 2012 Jun 5.
8
Spectrum of cancer risk among US solid organ transplant recipients.美国实体器官移植受者的癌症风险谱。
JAMA. 2011 Nov 2;306(17):1891-901. doi: 10.1001/jama.2011.1592.
9
Incidence of cancer after kidney transplant: results from the North Italy transplant program.肾移植后癌症的发病率：来自意大利北部移植项目的结果。
Transplantation. 2003 Nov 27;76(10):1448-51. doi: 10.1097/01.TP.0000083897.44391.E8.